News
Pfizer, Moderna Boost Hopes But Many Nations Counting On Oxford Vaccine
Trial successes from Pfizer Inc. and Moderna Inc. have buoyed hopes that a Covid-19 vaccine is coming soon. But much of the world, outside...
News
Russia Says Its Sputnik V COVID-19 Vaccine 95% Effective
Russia's Sputnik V coronavirus vaccine is 95 percent effective according to a second interim analysis of clinical trial data, its developers said on Tuesday....
News
Government of Canada signs new agreement for a COVID-19 antibody therapy
The Government of Canada is taking steps to provide Canadians with effective therapies as part of its response to COVID-19. The Honourable Anita Anand,...
News
Regeneron’s REGEN-COV2 is First Antibody Cocktail for COVID-19 to Receive FDA EUA
Regeneron Pharmaceuticals, Inc. announced that the antibody cocktail casirivimab and imdevimab administered together (also known as REGN-COV2 or REGEN-COV2), a therapy currently being investigated...
Drug Research
CureVac and WACKER Sign Manufacturing Contract for CureVac’s COVID-19 Vaccine Candidate
CureVac N.V., a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), and Wacker Chemie AG announced that...
Press Releases
Baxter Invests $50M to Expand Sterile Fill/Finish Manufacturing Operations
Baxter International Inc. has announced a $50 million expansion of its sterile fill/finish manufacturing facilities located in Bloomington, IN. These facilities are operated by...
Clinical Trials
Astrazeneca Says AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19
Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vaccine was highly effective in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read